Demystifying Your Ozempic Pen: Understanding How Many Shots It Holds

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The Ozempic pen is a convenient, prefilled injection device that delivers semaglutide in measured weekly doses. A standard Ozempic pen holds 2 mg of medication and can provide up to four weeks of once-weekly injections, making it an accessible option for people starting their weight loss journey. At PlexusDx, compounded semaglutide injections follow similar dosing principles while offering flexible, personalized treatment plans.

How Many Doses Does an Ozempic Pen Hold?

A standard Ozempic pen contains 2 mg of semaglutide total. Since the starting dose for weight management is 0.25 mg per week, one pen provides four weekly injections before it becomes empty. This means each pen supplies one month of treatment at the beginning dose level, though your healthcare provider may adjust your dosing schedule based on your individual response and tolerance.

The pen's design allows precise, easy-to-use weekly administration without requiring a separate needle or syringe for each injection. Once you have used all four doses from a pen, you dispose of it and start a new one. PlexusDx patients using compounded semaglutide injections receive prescriptions that align with this weekly dosing pattern, ensuring consistent supply and predictable refill timing.

Understanding Semaglutide Dose Escalation and Supply

Most semaglutide treatment plans follow a four-week escalation protocol, starting at 0.25 mg and increasing by 0.25 mg each week until reaching your target maintenance dose. During this escalation phase, each pen you receive contains the same total amount of medication but delivers a smaller individual dose per week. As your dose increases in later months, a single pen may supply fewer than four injections because each weekly dose is larger.

For example, once you reach the 1.0 mg weekly maintenance dose, one 2 mg pen will last approximately two weeks. This is normal and expected as your treatment progresses. Your PlexusDx provider calculates supply duration based on your current dose level, ensuring you never run out of medication and giving you accurate refill timelines. The key principle is that your dose may need to go up—but your price remains flat at $149 per month for compounded semaglutide injection, regardless of dose strength.

Tracking Your Pen Count and Refill Schedule

Keeping track of how many pens you have used helps you anticipate when you'll need your next refill. A simple approach is to mark your calendar each week after your injection, noting which pen you used and whether it's depleted. Most patients find it helpful to request their next refill when they open their second-to-last pen, giving the pharmacy time to prepare and ship their medication without treatment gaps.

PlexusDx makes refill management straightforward by maintaining your prescription records and supporting flexible delivery scheduling. Patients can request refills through the patient portal or contact customer support to ensure continuous medication supply. Since compounded semaglutide from licensed 503A compounding pharmacies follows the same weekly dosing schedule as branded Ozempic, your supply planning remains consistent whether you use brand-name or compounded options.

Choosing Between Ozempic Pens and Compounded Semaglutide

Branded Ozempic pens and compounded semaglutide injections deliver the same active ingredient and follow identical dosing protocols. The main difference lies in cost, accessibility, and customization options. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat-rate pricing model, making them more affordable than most branded options while requiring no insurance and serving all 50 states.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How long does one Ozempic pen last at the starting dose?

One Ozempic pen holds 2 mg of semaglutide and provides four weekly injections at the 0.25 mg starting dose, lasting approximately one month. As your dose increases during the titration phase, each pen will supply fewer injections because each weekly dose becomes larger. Your PlexusDx provider tracks your dose progression and schedules refills accordingly.

What happens if I need more doses per month as my dose increases?

As you progress through dose escalation, your weekly injection amount increases, meaning each pen delivers fewer total doses. At higher maintenance doses like 1.0 mg or 2.4 mg weekly, you will need more pens per month than during the starting phase. PlexusDx manages this automatically—your monthly price stays flat at $189 regardless of how many pens you require.

Can I switch from Ozempic pens to PlexusDx compounded semaglutide?

Yes, switching to PlexusDx compounded semaglutide injections is seamless because both follow identical weekly dosing schedules. PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies, costs significantly less than branded options, and works with any dose level. Many patients switch to save money while maintaining the exact same treatment protocol.

Is compounded semaglutide as safe as branded Ozempic?

PlexusDx compounded semaglutide comes exclusively from licensed 503A compounding pharmacies that follow strict FDA oversight and quality standards. The active ingredient and dosing are identical to branded Ozempic; the difference is manufacturing source and cost. Always discuss medication source with your provider, and report any concerns to ensure optimal safety.

How does the Precision Peptide Genetic Test help with my semaglutide treatment?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic What Is It
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.